Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)

Entrada Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $620000.0 for Q3 2025.

• On a quarterly basis, Current Taxes fell 72.46% year-over-year to $620000.0 in Q3 2025; TTM through Sep 2025 was $620000.0, a 72.46% decrease from a year earlier, with the FY2024 full-year figure at $667000.0, down 83.42% from the prior year.
• Current Taxes retreated to $620000.0 in Q3 2025 per TRDA's latest filing, from $802000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $7.4 million in Q2 2023 and bottomed at $620000.0 in Q3 2025.
• The 3-year median for Current Taxes is $3.1 million (2023), against an average of $3.2 million.
• Across the five-year window, Current Taxes plunged 44.14% in 2024 and slumped 86.3% in 2025, its largest moves.
• Year by year, Current Taxes stood at $4.0 million in 2023, then slumped by 83.42% to $667000.0 in 2024, then retreated by 7.05% to $620000.0 in 2025.
• Per Business Quant, the three latest TRDA Current Taxes figures stand at $620000.0 (Q3 2025), $802000.0 (Q1 2025), and $667000.0 (Q4 2024).